Reports and Publications

  • Connecticut Did Not Meet Federal and State Requirements for Claiming Medicaid School-Based Child Health Services for Hartford Public Schools
  • CMS releases new Manufacturer Release on the Misclassification of Drugs for the Medicaid Drug Rebate Program
  • Operationalizing Implementation of the Optional COVID-19 Testing (XXIII) Group­­ - Potential State Flexibilities Guidance
  • CMS Releases further recommendations on calculation of Average Manufacturer Price (AMP) of brand name drug and authorized generic drugs to drug manufactures
  • Medicaid Managed Care Options in Responding to COVID-19
  • CMS published new Medicaid and CHIP FAQs in a newly reorganized comprehensive document
  • New COVID-19 FAQs for State Medicaid and CHIP Agencies
  • CMS reopens the comment period for the Coordinating Care from Out-of-State Providers for Medicaid-Eligible Children with Medically Complex Conditions Request for Information
  • COVID-19 FAQs on implementation of Section 6008 of the Families First Coronavirus Response Act and Coronavirus Aid, Relief, and Economic Security (CARES) Act
  • Medicaid Substance Use Disorder Treatment via Telehealth, and Rural Health Care and Medicaid Telehealth Flexibilities guidance
  • COVID-19 FAQs on implementation of Section 6008 of the Families First Coronavirus Response Act
  • Section 1135 Waiver Approval - Washington Coronavirus Disease 2019
  • COVID-19 FAQs for State Medicaid and CHIP Agencies
  • Section 1135 Waiver Approval - Florida Coronavirus Disease 2019
  • Medicaid State Plan Fee-for-Service Payments for Services Delivered Via Telehealth
  • Coverage and Benefits Related to COVID-19 Medicaid and CHIP
  • Healthy Adult Opportunity Demonstration
  • Best Practices for Avoiding 340B Duplicate Discounts in Medicaid
  • Coordinating Care From Out-of-State Providers for Medicaid-Eligible Children With Medically Complex Conditions
  • 2020 SSI and Spousal Impoverishment Standards
Showing 1 to 20 of 134 results
1 2 3 > >>